[1]
M. Saleem, S. A. Khan, Z. A. Suchal, and N. Ram, “Clinical and biochemical outcomes of Sodium-Glucose CoTransporter-2 (SGLT2) Inhibitors in Type-2 Diabetes Mellitus Patients as a fourth oral anti diabetic medicine”, Pak J Med Sci, vol. 38, no. 5, May 2022.